Gupta Family Pilot Award in PSC Research
The 2022 application deadline for this program has passed. Notifications will be sent by May 1, 2022
View the 2022 request for applications [PDF].
The purpose of this award is to support new, highly innovative PSC research ideas that focus on questions pertaining to the pathogenesis, diagnosis, and/or management of PSC in children and/or adults. Responsive projects will address highly innovative research ideas that have a clear potential to produce high-impact results, but that have little or no preliminary data to successfully compete for funding from other sources. This award is not intended to support ongoing research in the applicant’s laboratory, but rather support new ideas or approaches that have not previously been studied.
In order to be eligible for this award, the applicant must adhere to the following guidelines:
- The applicant must:
- Be at the post-doctoral level (MD, PhD, PharmD, or equivalent), or faculty at or below the rank of Associate Professor at the start date of the award (July 1, 2022).
- Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
- Be able to devote at least 20% effort to the research project on which this application is based.
- Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
- If the applicant is at or below the rank of Assistant Professor, they must have a mentor or co-mentor who is an AASLD member in good standing at the time of application and for the duration of the award period. Mentors are not required for Associate Professor level applicants or equivalent.
- Not hold federal funding (e.g., U, P, R, K, VA Merit, VA CDA) unless they are able to justify the following in their application:
- The project is truly completely distinct and non-overlapping from existing funding.
- The proposed work cannot be completed using existing funds.
- The proposed project must:
- Focus on research pertaining to the pathogenesis, diagnosis, and/or management of PSC in children and/or adults.
- Not be an established project with alternate funding.
- Be conducted at the sponsoring institution within the United States, Canada, or Mexico.
- Application limits:
- There is no restriction on the number of applicants an institution can sponsor each cycle, but only one applicant may be funded per department within each institution for this award category.
- Applicants may only apply for one AASLD Foundation research award per application year. Eligible applicants in this category may also apply for the AASLD Foundation Advanced/Transplant Hepatology Award in the same award year.
Award Period: July 1, 2022 – June 30, 2023.
- One award of $50,000 will be provided over one (1) year.
- Funds may only be used for technical support/laboratory supplies (excluding capital equipment) for the recipient.
- If the funded candidate is a post-doctoral researcher, up to $10,000 may be used for PI salary support.
- No additional or indirect costs, registration fees, or travel expenses are allowed.
- Unexpended funds at the end of the award term must be returned to AASLD Foundation.
- Awards cannot be transferred to another institution without prior written approval from AASLD Foundation.
- Funding notifications for the 2022 awards cycle will be sent no later than May 15, 2022.
Applicants will be evaluated based upon their background, their commitment to a research career, the scientific merit of their research project and the environment in which they will conduct this project.
- Highly innovative, high-risk/high-reward projects will be prioritized.
- Project feasibility, an appropriate environment to conduct the project, and relevant collaborators will strengthen the application.
Applications will be reviewed based on the written materials submitted. Incomplete applications and applications that fail to adhere strictly to the instructions (including the submission deadline and page limitations) will not be reviewed. All decisions are final.
- Use pages 5-6 of the RFA as cover pages. Type responses.
- Include only the required documents and provide signatures as requested.
- Include a header at the upper right corner of each page with your name (last name, first name) and award name.
- Use half-inch margins. Do not use lettering smaller than 10 point.
- Adhere to page limits and complete all sections. Applications that do not meet the requirements, in content or format, will not be reviewed.
- The completed application, letters of support or commitment, and other documents as applicable must be combined in the order listed in the Required Documents section (RFA pages 3-4) and submitted as one PDF document. Name the PDF file as follows: 2022 GUPTA_Last name, first name (Example: 2022 GUPTA_Smith, Jane)
- Submit your application at www.liverresearchawards.org. You will be sent an email confirmation that the application was received. If an email confirmation is not received in two (2) business days, please contact firstname.lastname@example.org to confirm receipt.
The application deadline for this award is 11:59 pm Eastern time, December 2, 2021. Applications received after the deadline will not be reviewed.